# Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy

> **NCT02335671** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 40 (actual)

## Conditions studied

- Early Stage Breast Cancer
- Breast Cancer Stage I
- Breast Cancer Stage II

## Interventions

- **PROCEDURE:** Intra-operative Magnetic Resonance Imaging (MRI)
- **OTHER:** Mass Spectrometer Analysis of Tissue Sample

## Key facts

- **NCT ID:** NCT02335671
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2023-01
- **Final completion:** 2023-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02335671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02335671, "Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02335671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*